Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity

Journal of Immunology

Volumn 167, Issue 11, 2001, Pages 6356-6365

  Liu, K ^a   Rosenberg, S A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ADOPTIVE TRANSFER; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MELANOMA; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE ACTIVATION;

EID: 0035575701     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.11.6356     Document Type: Article

References (31)

1. T-cell survival and the role of cytokines
2. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy
3. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
4. Gene transfer into humans: Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction
5. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: A preliminary report
6. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients
7. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
8. Adoptive transfer of cloned, melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma
9. Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones
10. Progress in human tumor immunology and immunotherapy
11. Cell transfer therapy: Clinical implications: Melanoma
12. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen
13. Human gene marker/therapy clinical protocols
14. IL-2 gene therapy of advanced lung cancer patients
15. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease
16. + T lymphocytes by MuLV-10A1 retrovirus pseudotype
17. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
18. Green fluorescent protein retroviral vector
19. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
20. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
21. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments
22. Impaired assembly and transport of HLA-A and -B antigens in a mutant TXB cell hybrid
23. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp1OO modified at HLA-A*0201-binding residues
24. Cell-surface receptors for retroviruses and implications for gene transfer
25. Rapid selection of antigen-specific T lymphocytes by retroviral transduction
26. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
27. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: Implication for gene therapy of AIDS
28. The multi-subunit interleukin-2 receptor
29. Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity
30. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene
31. Retrovirus-mediated gene transfer into T cells: 95% Transduction efficiency without further in vitro selection